Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 9, 2015

View Archived Issues

Deciphera initiates phase I trial of KIT and PDGFR inhibitor DCC-2618

Copernicus receives FDA orphan drug designation for ABCA4 DNA nanoparticles

Takeda reflects on accomplishments of second quarter of fiscal 2015

InMed provides update on development program for epidermolysis bullosa

Allergan licenses dry eye candidate MIM-D3 from Mimetogen

Cel-Sci's RA vaccine selected for NIH commercialization and niche analysis plan

NIH grant supports City of Hope's research into chronic GvHD

Janssen initiates phase Ib trial of subcutaneous daratumumab in multiple myeloma

Preclinical toxicity study results for Pyridorin will support planned IND filing

New companies created: Evelo Therapeutics, Aziyo Biologics and Iron Horse Therapeutics

Global Health Innovative Technology Fund announces grants for infectious disease research

Ono Pharmaceutical presents update on second quarter of fiscal 2015

SUL-121, a novel candidate to treat diabetic nephropathy

Eisai begins two joint research agreements to develop new antimalarial medicines

IND gets submitted for TD-1473 gastrointestinal-targeted pan-JAK inhibitor from Theravance

New antimalarial strategy shows promising preclinical results

RSV vaccine candidate shows promise for children

Novartis reports autotaxin inhibitors

Gruenenthal patents dual cathepsin K and S inhibitors

HEC Pharm presents PDE4B inhibitors

China State Institute of Pharmaceutical Industry introduces podophyllotoxin derivatives

Australian team divulges Nix-based gene therapies for neurodegeneration

Ignyta licenses rights to Lilly's taladegib oncology program

Antagonism of CCR2/5 in type 2 diabetic nephropathy

Neurocrine starts phase I trial of essential tremor candidate NBI-640756

Transgenomic launches mutation profiling test for NSCLC

FDA accepts for review Amgen's NDA for etelcalcetide

Preliminary phase II results presented for a malaria vaccine adjuvant

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...